Zhejiang Xianju Pharmaceutical Co Ltd (002332) — Cash Flow-to-Debt Ratio
Zhejiang Xianju Pharmaceutical Co Ltd (002332) has a Cash Flow-to-Debt Ratio of 0.11x as of September 2025, meaning its operating cash flow of CN¥130.05 Million could theoretically repay 0% of its total liabilities (CN¥1.24 Billion) in one year. See how much free cash does Zhejiang Xianju Pharmaceutical Co Ltd generate to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Zhejiang Xianju Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (2006–2025)
Historical debt coverage capacity for Zhejiang Xianju Pharmaceutical Co Ltd across 20 annual periods. Also explore Zhejiang Xianju Pharmaceutical Co Ltd annual equity growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Zhejiang Xianju Pharmaceutical Co Ltd (2006–2025)
Year-by-year debt coverage analysis for Zhejiang Xianju Pharmaceutical Co Ltd. For market capitalisation and broader financial context, see 002332 company net worth.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.21x | CN¥247.48 Million | CN¥1.18 Billion | ▼ -41.4% |
| 2024 | 0.36x | CN¥398.66 Million | CN¥1.11 Billion | ▼ -30.0% |
| 2023 | 0.51x | CN¥595.48 Million | CN¥1.16 Billion | ▲ +3.4% |
| 2022 | 0.50x | CN¥609.28 Million | CN¥1.23 Billion | ▲ +30.2% |
| 2021 | 0.38x | CN¥676.15 Million | CN¥1.78 Billion | ▲ +8.7% |
| 2020 | 0.35x | CN¥789.23 Million | CN¥2.26 Billion | ▲ +86.1% |
| 2019 | 0.19x | CN¥519.81 Million | CN¥2.77 Billion | ▲ +165.8% |
| 2018 | 0.07x | CN¥193.27 Million | CN¥2.73 Billion | ▲ +16.1% |
| 2017 | 0.06x | CN¥167.47 Million | CN¥2.75 Billion | ▼ -45.9% |
| 2016 | 0.11x | CN¥155.91 Million | CN¥1.38 Billion | ▼ -27.4% |
| 2015 | 0.16x | CN¥199.61 Million | CN¥1.29 Billion | ▲ +72.5% |
| 2014 | 0.09x | CN¥141.64 Million | CN¥1.57 Billion | ▲ +122.8% |
| 2013 | 0.04x | CN¥63.46 Million | CN¥1.57 Billion | ▲ +49.8% |
| 2012 | 0.03x | CN¥33.43 Million | CN¥1.24 Billion | ▼ -84.3% |
| 2011 | 0.17x | CN¥147.63 Million | CN¥860.02 Million | ▼ -22.5% |
| 2010 | 0.22x | CN¥155.29 Million | CN¥701.29 Million | ▲ +64.6% |
| 2009 | 0.13x | CN¥104.68 Million | CN¥778.28 Million | ▲ +179.0% |
| 2008 | 0.05x | CN¥36.03 Million | CN¥747.44 Million | ▼ -67.8% |
| 2007 | 0.15x | CN¥96.53 Million | CN¥644.44 Million | ▲ +67.5% |
| 2006 | 0.09x | CN¥53.05 Million | CN¥593.35 Million | — |